Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00606190
Other study ID # 5985 Aortic Arch
Secondary ID
Status Completed
Phase N/A
First received December 27, 2007
Last updated February 15, 2017
Start date June 2003
Est. completion date April 2010

Study information

Verified date February 2017
Source The Cleveland Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research study is to evaluate two standard approaches of supplying blood and oxygen to your brain during open heart surgery.


Description:

The purpose of the clinical trial is to assess the best method of protecting the brain during long periods of circulatory arrest. The significance of this project will be to determine which method of brain protection (1) retrograde brain perfusion or (2) perfusion of the right subclavian artery with antegrade perfusion of the brain protects against brain injury after total arch replacement. Thus reducing the risk of stroke or neurocognitive deficits in patients undergoing this critical surgical procedure.


Recruitment information / eligibility

Status Completed
Enrollment 123
Est. completion date April 2010
Est. primary completion date April 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 74 Years
Eligibility Inclusion Criteria:

- Undergoing a total arch replacement

- Less than 75 years old

Exclusion Criteria:

- EF less than 35%

- Pt shows evidence of major illness e.g. severe hepatic disease, severe renal failure, active cancer or major infection

- Pt unable to complete preop neuro assessment

- Pt is unwilling or able to complete followup requirements

- Pt is already enrolled in other new device or drug protocols that have not completed the primary endpoint or that clinically interferes with study endpoint

- Pt is a female who is pregnant or lactating

- Pt has history of stroke

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Retrograde brain perfusion
observational
Antegrade brain perfusion
observational

Locations

Country Name City State
United States Cleveland Clinic Cleveland Ohio

Sponsors (1)

Lead Sponsor Collaborator
The Cleveland Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary To determine what is the best method of brain protection during long periods of circulatory arrest 6 months
Secondary Will one method of brain protection be better than the other in prevention of post-op stroke and which method will provide freedom from postop neurobehavioural deficit at 6 months postop. 6 months
See also
  Status Clinical Trial Phase
Completed NCT02264977 - Early Feasibility of the Branched TAG® Device in the Treatment of Aortic Arch Aneurysms N/A